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Thus, despite Katsnelson's interesting
model for testing arsenic for carcinogenicity
and his findings of a few unusual applica-
tion-site gastric tumors, we remain uncon-
vinced that the collective experimental find-
ings on arsenic can be taken as proof that
arsenic is carcinogenic to animals; by this we
mean, on the singular basis of the available
animal data (and, for the moment, ignoring
the human data), that neither IARC nor the
National Toxicology Program (NTP) would
judge arsenic as a "probable" or "reasonably
anticipated" human carcinogen. The available
animal data alone simply do not meet the cri-
teria for either IARC or the NTP to consider
the laboratory evidence as being adequate and
sufficient to list arsenic as a likely carcinogen
to humans. Of course, both organizations do
consider arsenic and arsenic compounds as
being unequivocally carcinogenic to humans
based on epidemiological data.
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Independent Review of
Industry-generated Data
The commentary ofGibson et al. (1) ofDow
AgroSciences takes issue with our estimates of
potential risks to children from indoor broad-
cast uses ofchlorpyrifos (2) that were derived
from a recent study by Gurunathan et al. (3)
at the Environmental and Occupational
Health Sciences Institute (EOHSI) of
Rutgers University. Specifically, the Dow
AgroSciences researchers claim that potential
indoor exposures ofchlorpyrifos are "approx-
imately 10 times below" those found in the
EOHSI study.
Unfortunately, there is no easy way to
examine the claim made by Gibson et al. (1)
because most of the pertinent data on which
their statement is based are not available in
the peer-reviewed, published literature. Thus,
we are unable to determine whether the test
protocols or exposure time periods used in
the previous unpublished Dow studies are
comparable to the experimental approaches
used in the EOHSI study. For example,
Gibson and colleagues' citation of biomoni-
toring data ofvolunteers (simulating childlike
activities) following broadcast spraying of
chlorpyrifos-demonstrating potential child-
hood exposures to be 10-fold below EOHSI
estimates-is based entirely on one internal,
unpublished Dow Chemical Company study
(4). Similarly, Dow AgroSciences' exposure
study after "crack and crevice" treatment by
chlorpyrifos for insect infestation is based on
an industry-sponsored study whose results
were only recently published (5).
On the other hand, Gurunathan et al. (3)
presented a detailed and well-conducted
assessment ofexposures to chlorpyrifos over a
2-week period following a one-time broad-
cast application of chlorpyrifos by a licensed
pesticide applicator. Most published studies
in the past that examined exposure levels
related to broadcast spraying of chlorpyrifos
did not measure the pesticide's indoor con-
centration beyond 1 or 2 days following
applications [for example, see Fenske et al.
(6)]. What the EOHSI study showed was
that chlorpyrifos, like other semiviolatile pes-
ticides, did not dissipate or settle down, but
continued to vaporize into the gas phase and
resettle on a variety of solid surfaces indoors
(such as children's toys) over an extended
period oftime.
Furthermore, the experimental protocols
used in the EOHSI study (3) simulated con-
ditions that may easily lead to an underesti-
mation of exposure to indoor uses of chlor-
pyrifos. As we stated in our commentary (2),
in a number offacilities where many children
are present
... such as day care centers, schools, and
homes, where chlorpyrifos-based products may
befrequendysprayed on to control insect infesta-
tions, there can be cumulative exposures that are
much higher than those currently estimated from
the [EOSHI] and other pesticide exposure stud-
ies based on single [broadcast] applications.
This exchange raises two pressing issues
for public policy. First, those in the public and
private sectors charged with developing
national guidelines and standards to protect
children from environmental hazards often
make decisions based on incomplete informa-
tion. Secondly, we agree with Gibson et al. (1)
that a weight-of-evidence approach is the best
way to resolve issues involving the safety of
widely used compounds such as chlorpyrifos.
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However, a weight-of-evidence approach can
onlyworkifthere is fill disclosure ofindustry-
generated unpublished studies. In order to
obtainscientific consensus on such matters, we
propose that technical reviews ofunpublished
industry data be carried out by scientists and
other technical experts working under the
aegis of institutions such as the National
Academy of Sciences, the Health Effects
Institute, or other similar independent organi-
zations. We would welcome the creation of
such institutional arrangements to make it
possible for exposure and health risk assess-
ments to be conducted on a complete scientif-
icknowledge base.
DevraL. Davis
A. KarimAhmed
World Resources Institute
Washington, DC
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EMF Working Group
A brief note on the results of the NIEHS
EMF working group was given in the
September issue of EHP [106:A431 (1998)].
It may be helpful if more details of the
NIEHS EMF working group deliberations
are provided.
The NIEHS EMF working group mem-
bers voted according to guidelines used in the
International Agency for Research on Cancer
(IARC) Monographs on the Evaluation ofthe
Carcinogenic Risk ofChemicals to Humans. No
members voted to classify EMFs as either a
known or probable human carcinogen (IARC
groups 1 and 2A), 19 members voted to clas-
sify EMFs as a possible human carcinogen
(IARC group 2B), 8 voted to classify EMFs as
not a human carcinogen (IARC group 3), and
1 voted to classify EMFs as probably not a
human carcinogen (IARC group 4).
GaryA. Boorman
EMFRAPIDProgram
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"Politically Correct" Research
It is unfortunate thattheNational Institutes of
Health have become so politicized. I do not
understand how the original study ofSwan et
al. [Have Sperm Densities Declined? A
Reanalysis of Global Trend Data. EHP
105:1228-1232 (1997)] got such widespread
attention; onewould expect the arguably most
important government organ concerned with
the study ofhealth issues in the United States
to have a higher standard than that exempli-
fied in its dissemination ofits original study.
David Hamlin
K-Sight Systems, Inc.
Memphis, Tennessee
Not if you subscribe to Environmental
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comprehensive, cutting-edge environmental health
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